# A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study of belimumab in patients with active systemic lupus erythematosus

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-phase-ii-randomized-double-blind-placebo-controlled-dose-ranging-study-of/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Daniel J. Wallace,William Stohl,Richard Furie,Jeffrey Lisse,James D. McKay,Joan T. Merrill,Michelle Petri,Ellen M. Ginzler,Winn Chatham,W. Joseph McCune,Vivian Fernandez,Marc Chévrier,Z. John Zhong,William W. Freimuth |
| Citations | 597 |
| DOI | 10.1002/art.24699 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/art.24699?download=true |
| OpenAlex ID | https://openalex.org/W2096286605 |
| PMID | 19714604 |
| Type | article |
| Year | 2009 |

## Paper authors

- [Daniel J. Wallace](https://scholariq.org/researchers/daniel-j-wallace/)
- [Joan T. Merrill](https://scholariq.org/researchers/joan-t-merrill/)
- [Michelle Petri](https://scholariq.org/researchers/michelle-petri/)
- [Richard Furie](https://scholariq.org/researchers/richard-furie/)

## Paper journal

- [Arthritis Care & Research](https://scholariq.org/journals/arthritis-care-and-research/)

## Paper primary topic

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

## Paper topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.